Read More 1 minute read Analyst Ratings Downgrades News RF Lafferty Downgrades Lordstown Motors to Sell By Benzinga Newsdesk Today, 3:36 PM RF Lafferty analyst Jaime Perez downgrades Lordstown Motors (NASDAQ:RIDE) from Hold to Sell. RIDE
Read More 8 minute read Analyst Ratings Downgrades Initiation Intraday Update Upgrades Benzinga’s Top Ratings Upgrades, Downgrades For June 14, 2021 By Benzinga Insights Today, 3:36 PM ATLC
Read More 1 minute read Analyst Ratings Downgrades News Price Target Wedbush Downgrades UWM Holdings to Neutral, Raises Price Target to $10 By Benzinga Newsdesk Today, 3:36 PM Wedbush analyst Henry Coffey downgrades UWM Holdings (NYSE:UWMC) from Outperform to Neutral and raises the price target from $9.25 to $10. UWMC
Read More 1 minute read Analyst Ratings Downgrades News Evercore ISI Group Downgrades AvalonBay Communities to In-Line By Benzinga Newsdesk Today, 3:36 PM Evercore ISI Group analyst Steve Sakwa downgrades AvalonBay Communities (NYSE:AVB) from Outperform to In-Line. AVB
Read More 1 minute read Analyst Ratings Downgrades News Evercore ISI Group Downgrades Equity Residential to In-Line By Benzinga Newsdesk Today, 3:36 PM Evercore ISI Group analyst Steve Sakwa downgrades Equity Residential (NYSE:EQR) from Outperform to In-Line. EQR
Read More 1 minute read Analyst Ratings Downgrades News Price Target DA Davidson Downgrades First Bancshares to Neutral, Raises Price Target to $44.5 By Benzinga Newsdesk Today, 3:36 PM DA Davidson analyst Kevin Fitzsimmons downgrades First Bancshares (NASDAQ:FBMS) from Buy to Neutral and raises the price target from $44 to $44.5. FBMS
Read More 1 minute read Analyst Ratings Downgrades News Evercore ISI Group Downgrades Camden Prop Trust to In-Line By Benzinga Newsdesk Today, 3:36 PM Evercore ISI Group analyst Richard Hightower downgrades Camden Prop Trust (NYSE:CPT) from Outperform to In-Line. CPT
Read More 1 minute read Analyst Ratings Downgrades News Price Target Citigroup Downgrades Core Laboratories to Sell, Raises Price Target to $36 By Benzinga Newsdesk Today, 3:36 PM Citigroup analyst Scott Gruber downgrades Core Laboratories (NYSE:CLB) from Neutral to Sell and raises the price target from $30 to $36. CLB
Read More 1 minute read Analyst Ratings Downgrades News Price Target Baird Downgrades Physicians Realty Trust to Neutral, Raises Price Target to $20 By Benzinga Newsdesk Today, 3:36 PM Baird analyst Amanda Sweitzer downgrades Physicians Realty Trust (NYSE:DOC) from Outperform to Neutral and raises the price target from $19 to $20. DOC
Read More 1 minute read Analyst Ratings Downgrades News Price Target Goldman Sachs Downgrades Ferrari to Sell, Announces $207 Price Target By Benzinga Newsdesk Today, 3:36 PM Goldman Sachs analyst George Galliers downgrades Ferrari (NYSE:RACE) from Buy to Sell and announces $207 price target. RACE